Nocion Therapeutics raised $23 million in its Series B extension, totaling $93 million, to support late-stage development of taplucainium for chronic cough.
Amount Raised
$23 Million
Round Type
Series B
WalthamBiotechnologyHealthcareDescription
Nocion Therapeutics, Inc. has raised $23 million from existing investors in an extension of its Series B financing, totaling $93 million. The funds will support the development of taplucainium for the treatment of chronic cough as part of the ASPIRE Phase 2b clinical trial. Results from this trial are expected in mid-2026, and the financing extends the company's operating runway through 2027
Quick answer
Nocion Therapeutics raised $23 Million in a Series B round, dated January 7, 2026. Nocion Therapeutics is based in Waltham, Massachusetts, United States.
- How much did Nocion Therapeutics raise?
- Nocion Therapeutics raised $23 Million in a Series B round on January 7, 2026.
- What does Nocion Therapeutics do?
- Nocion Therapeutics is a biopharmaceutical company developing novel treatments for silencing neurons.
- Where is Nocion Therapeutics based and how big is it?
- Nocion Therapeutics is based in Waltham, Massachusetts, United States.
- Who are the decision-makers at Nocion Therapeutics?
- Fundz holds 2 contacts at Nocion Therapeutics, including the Director of Pharmaceutical Development and Acting Head of Quality. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Nocion Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Korsana Biosciences raised $175M (Series A) on February 18, 2026.
- CytoDyn raised $19M on January 30, 2026.
- Artelo Biosciences raised $500K on January 30, 2026.
- Primmune Therapeutics raised $8.6M (Series B) on January 30, 2026.
- NeOnc Technologies raised $11M on January 29, 2026.
- Elysium Therapeutics raised $7.5M (Convertible Note) on January 28, 2026.
Who to call at Nocion Therapeutics, and when
A new round usually means Nocion Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Nocion Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nocion Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nocion Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nocion Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansNocion Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.